Abs 0714 at #ACR22 real-world obs study finds seropositive and seronegative RA patients had similar clinical effectiveness 1 year after starting bDMARD or JAKi. @RheumNow https://t.co/UrVgZ0zVno https://t.co/LnXMfOkQIp
Links:
Real-World Treatment Effectiveness of Disease-Modifying Anti-Rheumatic Drugs by…
http://ow.ly/Bl2Q50LvZ8F
13-11-2022
